Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Redirecting glucose flux during in vitro expansion generates epigenetically and metabolically superior T cells for cancer immunotherapy

Cell Metabolism(2025)10.1016/j.cmet.2024.12.007Source: DataRank Database

Redirecting glucose flux during in vitro expansion generates epigenetically and metabolically superior T cells for cancer immunotherapy is a research paper published in Cell Metabolism (2025). On theSindex it has a DataRank of 0. It has been cited 36 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access36 citations

Download PDF

Cite:

Linked data & code

geo gen uniprot

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (14 grants)Impact (FWCI 18.93)OA: greenTopics (40)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Yiyang Wang ORCID,Bingxian Xie ORCID,Aaron Yang ORCID,B. Rhodes Ford ORCID,Supriya Joshi ORCID

Live enrichment

PubMed:39879981 PMC:PMC12101091 OpenAlex:https://openalex.org/W4406903347

Stand up to Cancer

Grant: SU2C-AACR-IRG-04-16

National Institutes of Health

Grant: R01AI166598

National Institutes of Health

Grant: DP2AI136598

National Institutes of Health Office of Extramural Research

Grant: R01AI171483

Medical Center, University of Pittsburgh

Grant: P30CA047904

NCI NIH HHS

Grant: R01 CA277473

NIH HHS

Grant: S10 OD032141

NCI NIH HHS

Grant: F31 CA257760

NCI NIH HHS

Grant: T32 CA082084

Alliance for Cancer Gene Therapy

National Institutes of Health National Cancer Institute

Cancer Research Institute

National Institutes of Health Office of the Director

The Mark Foundation for Cancer Research

FWCI

18.93

Citation Percentile

1.0%

Citation Trend

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12101091/pdf/nihms-2052294.pdf

publisherhttps://api.elsevier.com/content/article/PII:S1550413124004893?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1550413124004893?httpAccept=text/plain

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12101091/

Fields of Study

CAR-T cell therapy researchCancer Immunotherapy and BiomarkersImmune Cell Function and Interaction

MeSH Terms

AnimalsDichloroacetic AcidGlucoseGlycolysisHumansImmunotherapyMice, Inbred C57BLMitochondriaNeoplasmsT-LymphocytesImmunotherapy, AdoptiveEpigenesis, GeneticCell Line, TumorCell ProliferationMice

Keywords

Cancer immunotherapyIn vitroImmunotherapyFlux (metallurgy)Cancer researchCancerCancer cellEpigeneticsBiologyCell biologyChemistryBiochemistryGeneGeneticsMitochondriaLongevityMetabolismGlucoseT cellCell therapyImmunometabolismCar-t

Sustainable Development Goals

SDG 0: Zero hunger